Lawmakers propose China restrictions and ASCO 2026 highlights

The latest Endpoints Weekly notes that U.S. lawmakers are introducing new measures aimed at limiting certain activities with China, though details were not disclosed in the brief.

The issue also recaps the team’s coverage from the recent ASCO conference in Chicago, highlighting key sessions and emerging data presented at the event.

Among the topics mentioned is Revolution Medicines’ landmark pancreatic research, which was featured in the conference coverage.

Readers are encouraged to sign up for free access to the full article and to receive newsletters directly to their inbox.